NexImmune | 10-K: Annual report
Apr 17 04:12
NexImmune | 3: Initial statement of beneficial ownership of securities-Officer Marchio Albert N II
Apr 11 05:18
NexImmune | 8-K: Current report
Apr 6 04:10
NexImmune | NT 10-K: Others
Mar 30 04:09
NexImmune | DEFA14A: Others
Feb 7 05:34
NexImmune | 8-K: Current report
Feb 6 06:15
NexImmune | 424B5: Prospectus
Feb 6 05:41
NexImmune | 8-K: Current report
Feb 3 02:31
NexImmune | 8-K: Current report
Feb 1 22:21
NexImmune | 8-K: Current report
Jan 19 13:00
NexImmune | DEFA14A: Others
Jan 18 13:00
NexImmune | 8-K: Current report
Dec 23, 2023 05:01
NexImmune | 8-K: Current report
Dec 2, 2023 02:39
NexImmune | 144/A: Others
Nov 23, 2023 06:40
NexImmune | 144/A: Others
Nov 23, 2023 06:34
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
Nov 23, 2023 06:18
NexImmune | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 22, 2023 05:39
NexImmune | DEF 14A: Definitive information statements
Nov 21, 2023 06:19
NexImmune | 8-K/A: Current report (Amendment)
Nov 21, 2023 06:01
NexImmune: Q3 2023 Earnings Report
Nov 18, 2023 05:03
No Data
No Data